ARCA biopharma Inc (ABIO) volume hits 80.69 million: A New Opening for Investors


ARCA biopharma Inc (NASDAQ: ABIO) started the day on Wednesday, with a price increase of 90.06% at $3.25, before settling in for the price of $1.71 at the close. Taking a more long-term approach, ABIO posted a 52-week range of $1.56-$2.16.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 48.59%. This publicly-traded company’s shares outstanding now amounts to $14.50 million, simultaneously with a float of $14.31 million. The organization now has a market capitalization sitting at $47.12 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7000, while the 200-day Moving Average is $1.8700.

ARCA biopharma Inc (ABIO) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. ARCA biopharma Inc’s current insider ownership accounts for 1.29%, in contrast to 51.56% institutional ownership.

ARCA biopharma Inc (ABIO) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 6/29/2020, the organization reported -$0.73 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$2.58) by $1.85. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

ARCA biopharma Inc (NASDAQ: ABIO) Trading Performance Indicators

Let’s observe the current performance indicators for ARCA biopharma Inc (ABIO). It’s Quick Ratio in the last reported quarter now stands at 59.01. The Stock has managed to achieve an average true range (ATR) of 0.21.

In the same vein, ABIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.37.

Technical Analysis of ARCA biopharma Inc (ABIO)

If we take a close look at the recent performances of ARCA biopharma Inc (NASDAQ: ABIO), its last 5-days Average volume was 16.17 million that shows progress from its year to date volume of 1.29 million. During the previous 9 days, stock’s Stochastic %D was recorded 52.03% While, its Average True Range was 0.2900.

Raw Stochastic average of ARCA biopharma Inc (ABIO) in the period of the previous 100 days is set at 72.84%, which indicates a major rise in contrast to 71.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 261.40% that was higher than 104.49% volatility it exhibited in the past 100-days period.